Sponsor or institution
Clinical trials and research at SOLTI Breast Cancer Research Group
As of November 12, 2026, Find a Trial lists 5 clinical trials run by SOLTI Breast Cancer Research Group that are recruiting, at sites in 3 countries (most in Spain (5), France (1), Germany (1)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Trastuzumab deruxtecan plus pertuzumab with proactive side-effect monitoring for first-line HER2-positive metastatic breast cancer | Phase 2 | Villejuif and 26 other locations | Recruiting | Jan 28, 2026 |
| Assessing Genomic Profiling's Impact on Metastatic Breast Cancer Treatment in Spain | — | Barcelona, Barcelona | Recruiting | May 28, 2025 |
| Treatment for advanced or metastatic breast cancer using sacituzumab govitecan | Phase 2 | Badalona, Barcelona and 9 other locations | Recruiting | Feb 1, 2024 |
| Elacestrant alone or with triptorelin for premenopausal luminal (HR+/HER2−) breast cancer | Phase 2 | Badalona, Barcelona and 14 other locations | Recruiting | Aug 8, 2023 |
| Exploring liquid biopsy genomic profiling for metastatic prostate cancer in Spain | — | Barcelona | Recruiting | Jun 1, 2023 |
All recruiting trials (5)
-
Trastuzumab deruxtecan plus pertuzumab with proactive side-effect monitoring for first-line HER2-positive metastatic breast cancer
This trial will try trastuzumab deruxtecan together with pertuzumab and digital tools to catch and manage side effects early in people starting first-line treatment for HER2-positive metastatic breast cancer.
-
Assessing Genomic Profiling's Impact on Metastatic Breast Cancer Treatment in Spain
This study is trying to see if using genetic information from patients with metastatic breast cancer in Spain can help doctors create better, personalized treatment plans for them.
-
Treatment for advanced or metastatic breast cancer using sacituzumab govitecan
This study is testing if a new drug called sacituzumab govitecan can help people with advanced breast cancer who haven't had success with other treatments.
-
Elacestrant alone or with triptorelin for premenopausal luminal (HR+/HER2−) breast cancer
This trial will test whether the oral drug elacestrant, given alone or with triptorelin (and compared to tamoxifen in Part B), changes tumor biology in premenopausal women with operable hormone receptor–positive, HER2‑negative breast cancer.
-
Exploring liquid biopsy genomic profiling for metastatic prostate cancer in Spain
This study is testing how analyzing blood and tumor samples can help doctors find better treatment options for men with advanced prostate cancer in Spain.
Quick answers
How many clinical trials run by SOLTI Breast Cancer Research Group are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Spain (5 trials), France (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.